Curcumin absorption study in healthy fasted adults
This study tests how a single dose of a new curcumin (turmeric-based) product is absorbed by the body in healthy people who have not eaten. It helps researchers understand if the product works as expected before larger studies.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 45 years old
- You have a BMI between 18.5 and 29.9
- You are generally healthy, with no major illnesses, and not taking prescription or herbal medications
- You are a non-smoker or smoke less than 10 cigarettes per day and can avoid smoking for 72 hours before the study
- You are willing to avoid foods containing turmeric or curry for a short time before and during the study
- If you are a woman able to have children, you must use birth control or be surgically sterile
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is an early-stage safety test of a new investigational drug called HSK56630 in healthy volunteers with no major medical conditions. Researchers will monitor how your body tolerates the drug and what side effects might occur.
This is an early-stage study testing a new drug called TL-003 to see if it's safe and how the body processes it. Researchers will first test it in healthy volunteers, then in people with ulcerative colitis (an inflammatory bowel disease) to understand if it might help reduce inflammation.
This study tests how a curcumin capsule (an ingredient found in turmeric) is processed by the body in healthy adults. It helps researchers understand the drug's safety and how it moves through the body.
This early-stage study tests whether curcumin (a natural plant compound) can affect eye changes in people who have amyloid deposits in the retina. It aims to see if the treatment is safe and possibly helpful for vision-related outcomes.
This trial tests whether a curcumin (turmeric) supplement can help women with advanced cervical cancer who are about to start standard treatment with chemotherapy and radiation. It aims to see if adding curcumin improves outcomes.
This trial tests whether curcumin, a natural compound found in turmeric, can reduce inflammation and improve symptoms like fatigue in people with certain blood disorders that cause low blood counts or overproduction of blood cells. It is for patients with clonal cytopenia of uncertain significance, low-risk myelodysplastic syndrome, or myeloproliferative neoplasms (polycythemia vera, essential thrombocytosis, or myelofibrosis) who have bothersome symptoms.
Hear when a new Healthy Volunteer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.